Skip to main content
Year archive

Essex Bio-Technology Limited — 2025 filings

All 40 regulatory filings released by Essex Bio-Technology Limited (1061) in 2025, sourced directly from the official regulator.

40 Filings
2025 Period
2025 filings (40)
Filing Released Lang
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025
Share Issue/Capital Change
2025-12-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025
Regulatory Filings
2025-11-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings
2025-10-02 English
INTERIM REPORT 2025
Interim / Quarterly Report H1 2025
2025-09-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings
2025-09-02 English
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025
Notice of Dividend Amount
2025-08-26 English
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H2 2025
2025-08-26 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-08-14 English
BIOLOGICS LICENSE APPLICATION ACCEPTED FOR THE LICENSED PRODUCT FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION
Regulatory Filings
2025-08-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2025
Regulatory Filings
2025-08-04 English
INSIDE INFORMATION APPROVAL TO COMMERCIALISE MULTI-DOSE DIQUAFOSOL SODIUM EYE DROPS IN THE PRC
Regulatory Filings
2025-07-23 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025
Regulatory Filings
2025-07-02 English
TERMS OF REFERENCE - NOMINATION COMMITTEE
Governance Information
2025-06-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025
Regulatory Filings
2025-06-03 English
AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information
2025-05-21 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 MAY 2025
Declaration of Voting Results & Voting Rights Announcements
2025-05-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025
Regulatory Filings
2025-05-02 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Report Publication Announcement
2025-04-03 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-03 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Report Publication Announcement
2025-04-03 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 21 MAY 2025 (or any adjournment thereof)
Proxy Solicitation & Information Statement
2025-04-03 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, AMENDMENTS TO ARTICLES OF ASSOCIATION, ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION AND NOTICE
Proxy Solicitation & Information Statement
2025-04-03 English
2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2025-04-03 English
ANNUAL REPORT 2024
Annual Report FY 2024
2025-04-03 English
INSIDE INFORMATION A PHASE 3 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION MET THE STUDY P
Regulatory Filings
2025-04-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
Regulatory Filings
2025-04-02 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND PROPOSED ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information
2025-04-01 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount
2025-03-26 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Annual Report FY 2024
2025-03-26 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-03-14 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025
Regulatory Filings
2025-03-04 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-02-26 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-02-10 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-02-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
Regulatory Filings
2025-02-04 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-01-27 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-01-13 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2025-01-08 English
LAST PATIENT LAST VISIT (LPLV) COMPLETED IN AN INTERNATIONAL MULTI-CENTRE PHASE 3 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (
Regulatory Filings
2025-01-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
Regulatory Filings
2025-01-02 English